John J. Schrogie

928 total citations
34 papers, 688 citations indexed

About

John J. Schrogie is a scholar working on Molecular Biology, Pharmacology and Pharmacology. According to data from OpenAlex, John J. Schrogie has authored 34 papers receiving a total of 688 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 9 papers in Pharmacology and 6 papers in Pharmacology. Recurrent topics in John J. Schrogie's work include Antibiotics Pharmacokinetics and Efficacy (6 papers), Drug-Induced Hepatotoxicity and Protection (4 papers) and Eicosanoids and Hypertension Pharmacology (3 papers). John J. Schrogie is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (6 papers), Drug-Induced Hepatotoxicity and Protection (4 papers) and Eicosanoids and Hypertension Pharmacology (3 papers). John J. Schrogie collaborates with scholars based in United States, Japan and Pakistan. John J. Schrogie's co-authors include Harvey M. Solomon, Philip D. Zieve, Richard O. Davies, Helen R. Skeggs, K. C. Yeh, Peter H. Vlasses, John Rogers, William B. Abrams, D. W. O. Rogers and C. Martin and has published in prestigious journals such as JAMA, Gastroenterology and Clinical Infectious Diseases.

In The Last Decade

John J. Schrogie

29 papers receiving 555 citations

Peers

John J. Schrogie

PHARM

CCM

PPCH

Renpei Nagashima United States

James M. Jaffe United States

Richard H. Reuning United States

S. M. Singhvi United States

D S Hewick United Kingdom

H.F. Woods United Kingdom

John J. Ashley Australia

Parviz Mojaverian United States

Chii‐Ming Lai United States

Yukinori Kawahara Japan

Renpei Nagashima United States

John J. Schrogie

204 ×1.2

203 ×1.3

PHARM

136 ×0.9

PHARM

87 ×1.0

CCM

69 ×0.9

PPCH

Citations per year, relative to John J. Schrogie John J. Schrogie (= 1×) peers Renpei Nagashima

Countries citing papers authored by John J. Schrogie

Since Specialization

Citations

This map shows the geographic impact of John J. Schrogie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John J. Schrogie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John J. Schrogie more than expected).

Fields of papers citing papers by John J. Schrogie

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John J. Schrogie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John J. Schrogie. The network helps show where John J. Schrogie may publish in the future.

Co-authorship network of co-authors of John J. Schrogie

This figure shows the co-authorship network connecting the top 25 collaborators of John J. Schrogie. A scholar is included among the top collaborators of John J. Schrogie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John J. Schrogie. John J. Schrogie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Artz, Margaret B., et al.. (2022). Estimating the National Population of Hospitalized Chronic Baclofen Users: A Cross-Sectional Analysis of a Commercial Claims Database. Drugs - Real World Outcomes. 9(2). 307–314. 1 indexed citations

Krach, Linda E., et al.. (2021). Characterizing Baclofen Withdrawal: A National Survey of Physician Experience. Pediatric Neurology. 122. 106–109. 4 indexed citations

Schrogie, John J.. (1999). Health system perspective regarding glycoprotein IIb/IIIa inhibitor therapy. American Heart Journal. 137(5). S126–S128. 1 indexed citations

Schrogie, John J., et al.. (1982). The use of cefadroxil suspension in children. Journal of Antimicrobial Chemotherapy. 10(suppl B). 153–160. 5 indexed citations

Vlasses, Peter H., Anne Holbrook, John J. Schrogie, et al.. (1980). Effect of orally administered probenecid on the pharmacokinetics of cefoxitin. Antimicrobial Agents and Chemotherapy. 17(5). 847–855. 22 indexed citations

Irvin, John D., et al.. (1980). Comparison of oral indacrinone with furosemide. Clinical Pharmacology & Therapeutics. 28(3). 376–383. 8 indexed citations

Schrogie, John J., et al.. (1979). Pharmacokinetics and Comparative Pharmacology of Cefoxitin and Cephalosporins. Clinical Infectious Diseases. 1(1). 90–97. 27 indexed citations

Löwenthal, David, G Onesti, Melton B. Affrime, et al.. (1978). The Diuretic Response in Normal Volunteers To a New Benzylamine, 2‐Aminomethyl‐4‐(1,1‐dimethylethyl)‐6‐iodophenol HCI. The Journal of Clinical Pharmacology. 18(8-9). 414–424. 2 indexed citations

Schrogie, John J., et al.. (1977). Evaluation of the prison inmate as a subject in drug assessment. Clinical Pharmacology & Therapeutics. 21(1). 1–8. 5 indexed citations

10.

Schrogie, John J.. (1972). Evaluation of the Carcinogenic Effect of the Sex Steroids. Australian and New Zealand Journal of Obstetrics and Gynaecology. 13(s1). 59–64. 2 indexed citations

11.

Schrogie, John J., et al.. (1971). Effects of Various Drugs on the Uterotropic Response to Mestranol and Norethynodrel in the Rat. Experimental Biology and Medicine. 136(1). 47–50. 6 indexed citations

12.

Schrogie, John J., et al.. (1968). Failure of probenecid to inhibit the rate of metabolism of tolbutamide in man. Clinical Pharmacology & Therapeutics. 9(3). 314–317. 10 indexed citations

13.

Schrogie, John J., Harvey M. Solomon, & Philip D. Zieve. (1967). Effect of oral contraceptives on vitamin K—dependent clotting activtiy. Clinical Pharmacology & Therapeutics. 8(5). 670–675. 47 indexed citations

14.

Solomon, Harvey M. & John J. Schrogie. (1967). The effect of phenyramidol on the metabolism of diphenylhydantoin. Clinical Pharmacology & Therapeutics. 8(4). 554–556. 46 indexed citations

15.

Schrogie, John J. & Harvey M. Solomon. (1967). II. The effect of D‐thyroxine, clofibrate, and norethandrolone. Clinical Pharmacology & Therapeutics. 8(1part1). 70–77. 64 indexed citations

16.

Solomon, Harvey M. & John J. Schrogie. (1967). Effect of phenyramidol and bishydroxycoumarin on the metabolism of tolbutamide in human subjects. Metabolism. 16(11). 1029–1033. 27 indexed citations

17.

Solomon, Harvey M. & John J. Schrogie. (1967). Change in receptor site affinity: A proposed explanation for the potentiating effect of D‐thyroxine on the anticoagulant response to warfarin. Clinical Pharmacology & Therapeutics. 8(6). 797–799. 25 indexed citations

18.

Solomon, Harvey M. & John J. Schrogie. (1967). The effect of various drugs on the binding of warfarin-14C to human albumin. Biochemical Pharmacology. 16(7). 1219–1226. 94 indexed citations

19.

Solomon, Harvey M. & John J. Schrogie. (1966). THE EFFECT OF PHENYRAMIDOL ON THE METABOLISM OF BISHYDROXYCOUMARIN. Journal of Pharmacology and Experimental Therapeutics. 154(3). 660–666. 39 indexed citations

20.

Schrogie, John J.. (1966). Cardiopulmonary Resuscitation in Practice. Public Health Reports (1896-1970). 81(2). 128–128. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact